BIO-Europe 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences
AP
Acadia Pharmaceuticals at BIO-Europe 2026
Nov 9–11, 2026 Cologne, Germany ~5.8k attendees Website
Acadia Pharmaceuticals at BIO-Europe 2026 in Cologne: 1 session (1 panel discussion).
| Organization | BIO-Europe 2026 Attendance |
|---|---|
AP Acadia Pharmaceuticals | |
Develops and markets medicines for neurological and rare diseases, including Parkinson's disease psychosis and Rett syndrome. | Panel Tue Nov 10 09:00–09:45 Networks or neurons: What’s next in CNS dealmaking? What is driving recent deals between biotechs and larger drug companies for brain and nervous system drugs, which remain hard to develop. |
Find decision makers at Acadia Pharmaceuticals
Tell us what you sell and we’ll find the people at Acadia Pharmaceuticals most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by BIO-Europe or its organizers. Submit a correction